Advertisement

Topics

Samsung Biologics to manufacture Sun Pharma’s psoriasis drug Tildrakizumab

02:55 EDT 5 Jul 2017 | Pharmaceutical Business Review

Indian drug major Sun Pharma has signed a manufacturing agreement with South Korea-based Samsung BioLogics for psoriasis experimental drug Tildrakizumab.

Original Article: Samsung Biologics to manufacture Sun Pharma’s psoriasis drug Tildrakizumab

NEXT ARTICLE

More From BioPortfolio on "Samsung Biologics to manufacture Sun Pharma’s psoriasis drug Tildrakizumab"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...